Optimi Health Corp.
corporate_fare Company Profile
Optimi Health Corp. (NASDAQ:OPTH) is a publicly traded company in the Life Sciences sector. Wiseek monitors OPTH SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Optimi Health Completes Third Commercial Psilocybin Export to Australia for Depression Treatment
- Optimi Health Completes Third Commercial Psilocybin Export to Australia
- Optimi Health Launches Standardized 1mg and 2mg Microdose Psilocybin Products for Clinical Research
- Optimi Health Completes First Psilocybin Export to UK for Phase 2 Clinical Trial
- Optimi Health Completes First Psilocybin Export to UK for Phase 2 Clinical Trial
Dilution Risk
Low riskFiling-implied dilution signals for OPTH, detected from its recent SEC filings · latest filing 2026-06-01.
Successful Nasdaq Public Offering · Resolution of Going Concern
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
OPTH files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.